Paclitaxel for Injection Clinical Trials
4 recruitingDrug
Phase 33Phase 22Phase 11
Showing 1–4 of 4 trials
Recruiting
Phase 3
Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)
Metastatic Pancreatic Ductal Adenocarcinoma
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.566 enrolled70 locationsNCT07165951
Recruiting
Phase 1Phase 2
A Study of SHR-7367 With Anti-tumor Agents in Patients With Solid Tumors
Solid Tumor
Shanghai Hengrui Pharmaceutical Co., Ltd.100 enrolled1 locationNCT07229586
Recruiting
Phase 3
A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer
PD-L1-positive Locally Recurrent Unresectable or Metastatic Triple-negative Breast Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.400 enrolled2 locationsNCT07111832
Recruiting
Phase 2Phase 3
BAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer
Cervical Cancer
Bio-Thera Solutions526 enrolled1 locationNCT06123884